What Cosara Diagnostics does

Cosara Diagnostics Pvt. Ltd. is an India-based joint venture incorporated in 2017 between Synbiotics Limited (Ambalal Sarabhai Enterprises) and Co-Diagnostics, Inc. (NASDAQ: CODX), headquartered in Ahmedabad with a 30,000 sq ft GMP manufacturing facility in Vadodara. The company manufactures in vitro molecular diagnostic products built on Co-Diagnostics' proprietary CoPrimer PCR technology, which is protected by US patents 10,093,966 and 10,704,087 and is claimed to deliver a 2.5 million-fold reduction in amplification errors relative to competing PCR methods. Its portfolio spans the SARAGENE real-time PCR kits (tuberculosis, HPV, hepatitis B/C, COVID-19, dengue, chikungunya, H1N1, malaria, drug-resistant TB), SARAPLEX multiplex kits, SARAQ viral load kits, SARAGENE Rapid card tests, and the Co-Dx Box / CoSara PCR Pro point-of-care instruments, covering 30+ pathogen targets across infectious disease and oncology-adjacent applications.

The company sells primarily through a network of regional distributors across South Asia (India, Bangladesh, Pakistan, Nepal, Sri Lanka) with direct enterprise sales into diagnostic chains, hospitals, and government health programs. Pricing is quote-based with multi-year institutional contracts, and the model combines one-time hardware sales (instruments, kits) with recurring reagent and cartridge revenue and CoPrimer technology licensing. Cosara holds ISO 13485:2016 certification for manufacturing and CDSCO approval for the CoSara PCR Pro instrument, and is pursuing Middle East and North Africa expansion through the CoMira Diagnostics joint venture with Arabian Eagle while exploring a SPAC transaction to fund further growth.

Name

Cosara Diagnostics

Legal name

Cosara Diagnostics Pvt. Ltd.

Website

https://cosara.in

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

Cosara Diagnostics is an India-based JV with Co-Diagnostics Inc. that manufactures IVD molecular diagnostic kits and point-of-care PCR instruments built on proprietary CoPrimer technology, serving hospitals, diagnostic chains, and government health programs across South Asia.

Ownership category

akta.pro rank

Product category

In Vitro Molecular Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)

akta.pro secondary industry

Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)

Keywords

• Molecular diagnostics
• PCR test kits
• Rapid diagnostics
• Point-of-care testing
• Infectious disease testing

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Molecular Diagnostic Products: Sale of molecular diagnostic kits and instruments including tuberculosis testing kits, multiplex PCR panels, and related reagents. One-time product sales model with repeat reagent orders.
2. Point-of-Care Devices: Sale of CoDx Box instruments and compatible test cartridges for point-of-care testing applications.
3. Technology Licensing: Licensing of CoPrimer technology to regional partners for manufacturing and distribution in specified territories.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Cosara Diagnostics manufactures in vitro molecular diagnostic products under GMP at its Vadodara facility, including SARAGENE Real-Time PCR kits for infectious diseases (tuberculosis, malaria, hepatitis B/C, HPV, COVID-19, dengue, chikungunya, H1N1), SARAPLEX multiplex PCR kits, SARAQ viral load kits, SARAGENE Rapid card-based diagnostics, and PCR instruments (Co-Dx Box, CoSara PCR Pro). The offerings are powered by proprietary CoPrimer PCR technology licensed from Co-Diagnostics Inc. and are sold to hospitals, diagnostic chains, laboratories, and government health programs across South Asia.

Product overview

Cosara Diagnostics offers a comprehensive molecular diagnostic portfolio centered on its proprietary CoPrimer® technology, which delivers 2.5 million times greater reduction in amplification errors than competing PCR technologies. The product ecosystem consists of four main product lines: (1) the Co-Dx Box™ System, a 48-reaction real-time PCR instrument platform; (2) SARAGENE® Real-Time PCR Kits covering 12 infectious disease tests including tuberculosis, malaria, hepatitis B/C, HPV, COVID-19, chikungunya, dengue, H1N1, and drug-resistant TB; (3) SARAPLEX® Real-Time PCR Multiplex Kits enabling simultaneous detection of multiple pathogens including flu/COVID-19, dengue-chikungunya, STI panel, and influenza differentiation; and (4) SARAQ® Real-Time PCR Viral Load Kits for quantitative HBV and HCV monitoring. Additionally, the company offers SARAGENE® Rapid Diagnostics card-based tests for point-of-care testing of HIV, hepatitis, syphilis, malaria, dengue, and typhoid. The CoPrimer technology enables mega multiplexing capabilities while virtually eliminating primer-dimers, the principal source of false positives in diagnostic testing.

Differentiator

Problem solved

Functional benefit

Brands

• SARAGENE®: Real-Time PCR In Vitro Diagnostic Kits for various pathogens including MTB, Malaria, Hepatitis B/C, HPV, COVID-19, Chikungunya, Dengue, DRTB, and H1N1
• SARAPLEX®
• SARAQ®
• SARAGENE® Rapid
• Co-Dx Box™
• CoSara PCR Pro®
• SARAGENE® product line
• Co-Dx™ PCR Platform

Products and services

• SARAGENE Real-Time PCR Kits Complete portfolio of real-time PCR in vitro diagnostic kits for infectious disease detection from respiratory, blood, cervical, and other clinical samples, sold to hospitals, diagnostic laboratories, and public health programs.
• SARAPLEX Real-Time PCR Multiplex Kits Multiplex real-time PCR test kits enabling simultaneous detection and differentiation of multiple pathogens (Flu A/B + COVID-19, Dengue + Chikungunya, STI panel, Influenza subtypes) in a single reaction, sold to diagnostic laboratories.
• SARAQ Real-Time PCR Viral Load Kits Quantitative real-time PCR kits for viral load monitoring of Hepatitis B (HBV genotypes A-H) and Hepatitis C (HCV genotypes 1-6) from blood plasma/serum samples, validated against WHO International Standards, sold to diagnostic laboratories and clinical monitoring programs.
• SARAGENE Rapid Diagnostics Card Tests Card-based rapid immunochromatographic diagnostic tests for point-of-care detection of HIV (1/2), Hepatitis B Surface Antigen, HCV antibodies, Syphilis, Malaria pLDH/HRP II, Dengue NS1 antigen, Dengue NS1/IgG/IgM combo, and Typhoid IgG/IgM antibodies, sold to clinics, hospitals, and field screening programs.
• Co-Dx Box Real-Time PCR System A 48-reaction real-time PCR system utilizing magnetic induction technology, designed for point-of-care molecular diagnostics with low maintenance requirements and easy-to-read results, sold to diagnostic laboratories, hospitals, and remote healthcare facilities.
• CoSara PCR Pro Instrument Point-of-care PCR instrument platform for molecular diagnostics, manufactured by Cosara under license from Co-Diagnostics Inc. for sale to diagnostic laboratories and healthcare institutions in India.

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• Co-Diagnostics, Inc. (USA)flagshipStrategic or Co-development PartnerJoint venture partnership with Co-Diagnostics Inc. (NASDAQ: CODX) for the India market. Provides Cosara with access to Co-Diagnostics' proprietary CoPrimer technology, US manufacturing capabilities, and global technology validation. Cosara serves as exclusive licensee and manufacturer in India.
• Arabian EaglecoreChannel Partner/ Reseller/ DistributorRegional distribution partner for CoMira Diagnostics products in Saudi Arabia. Enables market expansion into the Middle East region through established local distribution network.
• Bio Molecular SystemscoreTechnology or IntegrationManufacturing partner for CoDx Box point-of-care diagnostic device. Collaboration for production and supply of portable molecular diagnostic instruments.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Cepheid (Danaher): Global leader in molecular diagnostics with the GeneXpert system, dominant in TB (Xpert MTB/RIF) testing worldwide including India. Sets the benchmark Cosara's Co-Dx Box/PCR Pro must match in speed, footprint, and installed base.
• Qiagen: Provides molecular sample preparation and PCR testing kits for infectious disease and HPV. Overlaps with Cosara's SARAGENE HPV and viral load kits and serves similar lab customers in South Asia.
• Roche Diagnostics: One of the largest diagnostics companies globally, with cobas systems for viral load (HBV/HCV/HIV), HPV, and infectious disease molecular testing. A high-end competitor with deep presence in Indian private hospital networks.
• Abbott Molecular: Broad molecular diagnostics portfolio (Alinity m, m2000) covering infectious disease, viral load, and HPV testing globally. Competes with Cosara in Indian hospital labs and large diagnostic chains on viral load (HBV/HCV) and HPV testing.
• Hologic: Panther/Panther Fusion molecular diagnostics platform used in labs for high-volume infectious disease and women's health testing. Competes with Cosara for HPV and infectious disease testing contracts at large Indian diagnostic chains.

Emerging players

• SD Biosensor: Korean diagnostics company with strong presence in rapid point-of-care and molecular diagnostics for infectious diseases across emerging markets. Increasingly active in India and South Asia, competing on price-sensitive tenders similar to Cosara's government channel.
• Bioneer: South Korean molecular diagnostics company with the ExiStation and AccuPower PCR platforms for infectious disease testing. Comparable in scale and product positioning to Cosara's Co-Dx Box platform in emerging Asia.

Direct peers

• Molbio Diagnostics: Indian molecular diagnostics company with the Truenat point-of-care PCR platform widely deployed for TB and other infectious disease testing across India and emerging markets. Closest direct competitor to Cosara in the same geography and same product categories (TB MTB, multiplex respiratory panels).
• Mylab Discovery Solutions: Indian diagnostics manufacturer with a broad molecular and rapid test portfolio across infectious diseases, including COVID-19, TB, HPV, and hepatitis. Competes directly with Cosara in India's hospital, lab, and government health channels.

Others

• Co-Diagnostics (NASDAQ: CODX): Parent JV partner and CoPrimer technology licensor. Not a competitor but the closest relationship-of-record; its instrument roadmap (Co-Dx PCR Pro, sample prep instruments) determines Cosara's product cadence. Included for completeness as the upstream technology platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/CoSaraIndia

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cosara Diagnostics